DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹4,643 Cr | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr | ₹3,570 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹4,643 Cr |
| Mar2024 | ₹4,543 Cr |
| Mar2023 | ₹5,888 Cr |
| Mar2022 | ₹2,811 Cr |
| Mar2021 | ₹3,570 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,643 Cr | 2.19 | |
| Mar2024 | ₹4,543 Cr | -22.83 | |
| Mar2023 | ₹5,888 Cr | 109.46 | |
| Mar2022 | ₹2,811 Cr | -21.27 | |
| Mar2021 | ₹3,570 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹101,896.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
| MANKIND PHARMA | ₹90,642.6 Cr | 3.4% | 6.2% | -11.7% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.2% |
-4.9% |
6.6% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses